Skip to Main text

Americas

Press Release 2019

Select Category
2019/Jul/19
Alliance with Drug Discovery Gateway Investment Limited Partnership to Accelerate the Commercialization of the New Transdermal Therapeutic System (“PassPort System”)
2019/Jun/18
Sumitomo Dainippon Pharma and Nitto Denko Announce the Approval of Atypical Antipsychotic LONASEN® Tape in Japan
2019/Jun/07
Launch of Bisono® Tape 2mg, a Transdermal Patch Containing a β1 Blocker
2019/Apr/18
Established a Collaborative Research Department for the Development of New Nucleic Acid Drugs
2019/Feb/27
The Nitto ATP Finals charitable activities in support of UNICEF
2019/Jan/23
Nitto Named One of 2018-19 Derwent Top 100 Global Innovators, Marking its Eighth Consecutive Year on the List
2019/Jan/08
Additional Approvals for Bisono®Tape, a Transdermal Patch containing a β1Blocker, for Atrial Fibrillation, for a 2 mg strength and for improved formulations of 4 mg and 8 mg strengths in Japan

Contact Us

For any inquiries about Press Release.

Business Hours (EST)
8:00 a.m.-5:30 p.m.(Except for Sat, Sun, and Holidays)

Notice
Here is the information at the release day. This information may be different from the information at other medias. Please be forewarned.

Back to Page Top